These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 35059640)
1. A functional artificial neural network for noninvasive pretreatment evaluation of glioblastoma patients. Zander E; Ardeleanu A; Singleton R; Bede B; Wu Y; Zheng S Neurooncol Adv; 2022; 4(1):vdab167. PubMed ID: 35059640 [TBL] [Abstract][Full Text] [Related]
2. Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling. Zheng S; Wu Y; Li Z Radiother Oncol; 2021 Jan; 154():36-44. PubMed ID: 32918970 [TBL] [Abstract][Full Text] [Related]
3. Predicting Survival in Glioblastoma Using Gene Expression Databases: A Neural Network Analysis. Azimi P; Yazdanian T; Zohrevand A; Ahmadiani A Int J Mol Cell Med; 2024; 13(1):79-90. PubMed ID: 39156868 [TBL] [Abstract][Full Text] [Related]
4. AI Deployment on GBM Diagnosis: A Novel Approach to Analyze Histopathological Images Using Image Feature-Based Analysis. Cheung EYW; Wu RWK; Li ASM; Chu ESM Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894430 [TBL] [Abstract][Full Text] [Related]
5. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database. Lei CG; Jia XY; Sun WJ Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982 [TBL] [Abstract][Full Text] [Related]
6. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes. Sintupisut N; Liu PL; Yeang CH Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387 [TBL] [Abstract][Full Text] [Related]
7. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing. Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341 [TBL] [Abstract][Full Text] [Related]
8. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients. Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757 [TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme. Zheng S; Tao W Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33804433 [TBL] [Abstract][Full Text] [Related]
10. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction. Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H Front Oncol; 2020; 10():590352. PubMed ID: 33392085 [TBL] [Abstract][Full Text] [Related]
11. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma. Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762 [TBL] [Abstract][Full Text] [Related]
13. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients. Chaddad A; Sabri S; Niazi T; Abdulkarim B Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951 [TBL] [Abstract][Full Text] [Related]
14. Is age an additional factor in the treatment of elderly patients with glioblastoma? A new stratification model: an Italian Multicenter Study. Ius T; Somma T; Altieri R; Angileri FF; Barbagallo GM; Cappabianca P; Certo F; Cofano F; D'Elia A; Della Pepa GM; Esposito V; Fontanella MM; Germanò A; Garbossa D; Isola M; La Rocca G; Maiuri F; Olivi A; Panciani PP; Pignotti F; Skrap M; Spena G; Sabatino G Neurosurg Focus; 2020 Oct; 49(4):E13. PubMed ID: 33002864 [TBL] [Abstract][Full Text] [Related]
15. Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme. Zheng S; Li Z Aging (Albany NY); 2020 Sep; 12(17):17380-17392. PubMed ID: 32931454 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of Wang H; Wang X; Xu L; Zhang J; Cao H Front Oncol; 2021; 11():551160. PubMed ID: 33959491 [No Abstract] [Full Text] [Related]
17. Deep learning identified glioblastoma subtypes based on internal genomic expression ranks. Mao XG; Xue XY; Wang L; Lin W; Zhang X BMC Cancer; 2022 Jan; 22(1):86. PubMed ID: 35057766 [TBL] [Abstract][Full Text] [Related]
18. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the Lehrer S; Rheinstein PH; Rosenzweig KE Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632 [TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme. Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472 [TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of an immune-based prognostic score model in glioblastoma. Qin Z; Zhang X; Chen Z; Liu N Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]